Wang Tingting, Jiang Yuhua, Chu Lei, Wu Tianhui, You Jie
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of MedicineShanghai 200011, China.
Tumor Hospital of QingdaoShandong 266042, China.
Am J Cancer Res. 2017 Apr 1;7(4):999-1015. eCollection 2017.
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. The present study is aimed to investigate the role of alpinumisoflavone (AIF), a naturally occurring flavonoid compound, in ccRCC and the underlying mechanism. In this study, miR-101 has been identified as a novel therapeutic target, which exerts anti-tumor effect on ccRCC by directly targeting RLIP76. Moreover, our results showed that AIF was able to increase the expression of miR-101 by suppressing Akt signalling. Our findings in this study provided experimental evidence that AIF has the potential to be used as an agent in the treatment of ccRCC.
透明细胞肾细胞癌(ccRCC)是最常见的肾癌类型。本研究旨在探讨天然存在的黄酮类化合物高山槐黄素(AIF)在ccRCC中的作用及其潜在机制。在本研究中,miR-101已被确定为一个新的治疗靶点,它通过直接靶向RLIP76对ccRCC发挥抗肿瘤作用。此外,我们的结果表明,AIF能够通过抑制Akt信号传导来增加miR-101的表达。我们在本研究中的发现提供了实验证据,表明AIF有潜力用作治疗ccRCC的药物。